Hemophilia Treatment Company Catalyst Biosciences’ Antibody Update May Catalyze Shares

By |2020-10-20T14:54:04-04:00December 12th, 2018|Tags: |

Catalyst Biosciences, Inc. (NASDAQ:CBIO) , a company that is developing improved treatments for hemophilia, expects to update investors on December 18, [...]